Nurse Practitioner, Acute Care · Portland, OR
NPI
1003065640
Since 2008
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3181 SW Sam Jackson Park Rd
Portland, OR, 97239
Phone (503) 494-3988
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,988
132 services
Medicare patients, 2024
34
Average age 54
Drug cost, 2024
$645K
2,361 prescriptions
Company payments, 2023
$142
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anjalee N Rowe was code 99215 (office e&m - established), 31 times for 19 patients. In total Anjalee N Rowe billed 132 services in 11 codes, and Medicare paid $5,988.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 31 | 19 | $81.08 | $2,513 |
| 99215 Office E&M - Established | Office | 15 | 11 | $99.14 | $1,487 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 13 | 11 | $10.85 | $141 |
By year: 2022 $5,558 for 116 services; 2023 $5,736 for 108 services; 2024 $5,988 for 132 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anjalee N Rowe prescribed most often to Medicare patients was Lamotrigine, with 288 prescriptions and refills. In total Anjalee N Rowe wrote 2,361 Medicare prescriptions that cost $645K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 288 | 327 | 34 | $4,652 |
| Lamotrigine Er Lamotrigine | 208 | 264 | 19 | $58K |
| Lacosamide Generic | 183 | 222 | 27 | $16K |
| Clonazepam Generic | 180 | 198 | 25 | $1,411 |
| Divalproex Sodium Generic | 105 | 120 | Under 11 | $3,452 |
| Levetiracetam Generic | 101 | 136 | 17 | $4,162 |
| Carbamazepine Er Carbamazepine | 85 | 116 | 11 | $10K |
| Clobazam Generic | 83 | 92 | 19 | $7,146 |
| Topiramate Generic | 75 | 100 | 13 | $1,531 |
| Levetiracetam Er Levetiracetam | 74 | 119 | 13 | $9,152 |
| Gabapentin Generic | 68 | 93 | 14 | $3,189 |
| Lorazepam Generic | 68 | 68 | 18 | $322 |
| Xcopri Cenobamate | 61 | 71 | 11 | $74K |
| Divalproex Sodium Er Divalproex Sodium | 57 | 72 | Under 11 | $3,506 |
| Phenytoin Sodium Extended Generic | 55 | 55 | Under 11 | $816 |
Brand drugs: 260 claims; generic drugs: 2,068 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Anjalee N Rowe $142 ($142 in general payments such as food, travel and fees) from 1 company. The largest payer was Jazz Pharmaceuticals Inc. with $142.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.